A clinical formulation indicated for Antibiotics. This product supports the bacterial infection treatment process by inhibiting key enzymes necessary for microorganism replication and survival.
A broad-spectrum fluoroquinolone formulated to manage serious bacterial infections and intended to alleviate symptoms of pneumonia to support rapid clinical recovery.
Mechanism of Action
It inhibits bacterial topoisomerase IV and DNA gyrase. This stops DNA replication and repair, leading to the death of the bacteria.
Route of Administration
Oral
Onset Time
Within 24 hours
Duration
24 hours
Contraindications
History of tendon rupture, Myasthenia gravis, Allergy to quinolones
Information for Levofloxacin is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.